Next 10 |
Brainstorm Cell Therapeutics (BCLI) -69% after announcing topline results from Phase 3 trial evaluating NurOwn.Alterity Therapeutics (ATHE) -24%.iBio (IBIO) -20% on FQ1 earnings release.The Alkaline Water Company (WTER) -17% on FQ2 earnings release.GoodRx Holding...
MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding PR Newswire CEDAR KNOLLS, N.J., Nov. 17, 2020 CEDAR KNOLLS, N.J. , Nov. 17, 2020 /PRNewswire/ -- MYOS RENS Techno...
MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger PR Newswire CEDAR KNOLLS, N.J., Nov. 12, 2020 CEDAR KNOLLS, N.J. , Nov. 12, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") ...
MYOS RENS Technology (MYOS): Q3 GAAP EPS of -$0.07.Revenue of $0.49M (+40.0% Y/Y)Press Release For further details see: MYOS RENS Technology reports Q3 results
MYOS RENS Technology Announces Net Revenues Increase 39% for the Three Months Ended September 30, 2020 Net Revenues Increased 16% for the nine months ended September 30, 2020 PR Newswire CEDAR KNOLLS, N.J., Nov. 6, 2020 CEDAR KNOLLS, N.J. , Nov. 6, 2020 /...
CEDAR KNOLLS, N.J. , Sept. 9, 2020 /PRNewswire/ -- MYOS RENS Technology , Inc. ("MYOS") (NASDAQ: MYOS), "The Muscle Health Company" and owner of the advanced nutrition supplement Fortetropin ® , announced today that it has hired The S3 Agency (S3). The Boonton -...
NEW YORK , Aug. 7, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP 1...
MicroVision MVIS -30% on Q2 earnings . More news on: Citius Pharmaceuticals, Inc., MYOS RENS Technology Inc., Professional Diversity Network, Inc., Stocks on the move, , Read more ...
Gainers : IMAC Holdings (NASDAQ: IMAC ) +59% . More news on: IMAC Holdings, Inc., MYOS RENS Technology Inc., Marathon Patent Group, Inc., Stocks on the move, Read more ...
MYOS RENS Technology (NASDAQ: MYOS ) : Q2 GAAP EPS of -$0.07. Revenue of $0.33M (+120.0% Y/Y) Press Release More news on: MYOS RENS Technology Inc., Earnings news and commentary, Healthcare stocks news, ,
News, Short Squeeze, Breakout and More Instantly...
Myos Rens Technology Company Name:
MYOS Stock Symbol:
NASDAQ Market:
MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding PR Newswire CEDAR KNOLLS, N.J., Nov. 17, 2020 CEDAR KNOLLS, N.J. , Nov. 17, 2020 /PRNewswire/ -- MYOS RENS Techno...
MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger PR Newswire CEDAR KNOLLS, N.J., Nov. 12, 2020 CEDAR KNOLLS, N.J. , Nov. 12, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") ...
MYOS RENS Technology Announces Net Revenues Increase 39% for the Three Months Ended September 30, 2020 Net Revenues Increased 16% for the nine months ended September 30, 2020 PR Newswire CEDAR KNOLLS, N.J., Nov. 6, 2020 CEDAR KNOLLS, N.J. , Nov. 6, 2020 /...